The 18 graduates begin careers after completing an accelerated three-year medical degree.

The company, with a majority-female leadership team, will be headquartered in Jersey City with a singular vision: To make a better and healthier every day for every woman.

Scynexis Inc. in Jersey City is partnering with Amplity Health, a global contract commercialization organization, to support U.S. commercialization of the treatment, with a commercial launch scheduled in the second half of 2021.

The closures mark a shift toward hyperlocal deployment of vaccination efforts, as the state attempts to inoculate hundreds of thousands of vaccine-hesitant New Jerseyans. More than 2 million people have gotten their shots at one of the six mega-centers.

Health care industry veteran Warren Moore assumes a new role to advance the network’s strategic growth.

Unlike a version pulled in May, this proposal would employ legislative oversight for emergency powers the governor intends to use through Jan. 11, and he could ask lawmakers for a 90-day extension.

The Franklin Lakes-based medical technology company said it is the first in the industry to be authorized as a Common Vulnerability and Exposures numbering authority.

Hesitancy is dropping - albeit slowly - among a particularly challenging demographic to inoculate against COVID-19.

The first six-in-one vaccine in the U.S., Vaxelis is now available to help protect infants and children against diseases caused by six infectious agents.

The chief executive officer of PTC Therapeutics talks about the origins and development of the South Plainfield-based biopharmaceutical company's internship program.

The president and CEO of University Hospital in Newark talks about his testimony on vulnerable supply chains before a U.S. Senate committee and what he's most worried about while the issue remains unresolved.

“AtlantiCare has long been committed to preventing and addressing social inequities and disparities in health care,” says President and Chief Executive Officer Lori Herndon. “In 2020, we embraced the fact that we needed to do more. Spurred by nationwide social unrest, we recognized a powerful opportunity to re-evaluate our organizational culture and commitment to diversity, equity and inclusion (DE&I).”